SCHEMBL29348473

SCHEMBL29348473

O=C1CCC(c2cccc(-c3ccc(NC(=O)N4CCCC4)cc3)c2Cl)C(=O)N1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.41
NPSR1 Q6W5P4 3/20 0.41
MEN1 O00255 3/20 0.41
ALDH1A1 P00352 2/20 0.41
RECQL P46063 1/20 0.41
DDB1 Q16531 4/20 0.40
CRBN Q96SW2 4/20 0.40
ALOX5 P09917 1/20 0.39
MAPT P10636 3/20 0.39
RAB9A P51151 5/20 0.38
NPC1 O15118 4/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
TP53 P04637 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31068201 1.00 KMT2A (0.41) KMT2ANPSR1MEN1ALDH1A1RECQL
SCHEMBL29348412 0.85 CREBBP (0.48) KMT2AMEN1ALDH1A1DDB1CRBN
SCHEMBL29348783 0.84 CREBBP (0.47) KMT2AMEN1ALDH1A1DDB1CRBN
SCHEMBL31068121 0.84 CREBBP (0.47) KMT2AMEN1ALDH1A1DDB1CRBN
SCHEMBL31068101 0.83 PRKAB2 (0.39) ALDH1A1DDB1CRBNNPC1SMN1; SMN2
SCHEMBL29348461 0.83 PRKAB2 (0.39) ALDH1A1DDB1CRBNNPC1SMN1; SMN2
SCHEMBL29348366 0.80 DDB1 (0.49) ALDH1A1DDB1CRBN
SCHEMBL31068093 0.80 BRD4 (0.45) ALDH1A1DDB1CRBN
SCHEMBL29348361 0.80 DDB1 (0.46) ALDH1A1DDB1CRBN
SCHEMBL31068228 0.79 ROCK1 (0.46) KMT2AMEN1DDB1CRBNRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024151547-A1 TARGETED DEGRADATION OF VAV1 MONTE ROSA THERAPEUTICS, INC. (US) 2024-07-18 WO disclosed